Market Overview

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash

Related MYL
Mylan Inks Two Separate Agreements - Analyst Blog
Mylan Launches Generic Lunesta Tablets
Pfizer Loses Bid to Hold Celebrex Exclusivity to '15 (Fox Business)
Related SLXP
Flamel Technologies (FLML) in Focus: Stock Slumps 13.5% - Tale of the Tape
Pacira Prices Offering, Shares Soar - Analyst Blog

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash.

Salix Pharmaceuticals (NASDAQ: SLXP) had $775.90 million in total cash and $869.10 million in total debt for the latest quarter.

Mylan (NASDAQ: MYL) had $412.67 million in total cash for the latest quarter. However, Mylan had $5.37 billion in total debt for the same period.

Hi Tech Pharmacal Co (NASDAQ: HITK) had $104.09 million in total cash and $1.42 million in total debt for the latest quarter.

Akorn (NASDAQ: AKRX) had $38.40 million in total cash and $103.65 million in total debt for the latest quarter.

Posted-In: Drugs-Generic Industry highest cash NASDAQ StocksTrading Ideas

 

Most Popular

Related Articles (AKRX + HITK)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free